Psychiatry and Neurology, Neurology · Caguas, PR
NPI
1639379266
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
500 Ave Degetau Hima Plaza I, Suite 308 Piso 3
Caguas, PR, 00725
Phone (787) 474-7678
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,852
31 services
Medicare patients, 2023
14
Average age 78
Drug cost, 2024
$7.4M
2,361 prescriptions
Company payments, 2025
$20K
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Patricia de Jesus prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 327 prescriptions and refills. In total Patricia de Jesus wrote 2,361 Medicare prescriptions that cost $7.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dalfampridine Er Dalfampridine | 327 | 327 | 32 | $55K |
| Kesimpta Pen Ofatumumab | 215 | 215 | 24 | $2.0M |
| Pregabalin Generic | 190 | 191 | 16 | $6,782 |
| Baclofen Generic | 177 | 177 | 37 | $2,937 |
| Gabapentin Generic | 151 | 194 | 32 | $2,048 |
| Ampyra Dalfampridine | 83 | 83 | Under 11 | $361K |
| Emgality Pen Galcanezumab-Gnlm | 82 | 82 | Under 11 | $60K |
| Duloxetine Hcl Generic | 74 | 84 | 14 | $795 |
| Vumerity Diroximel Fumarate | 67 | 67 | Under 11 | $580K |
| Tizanidine Hcl Generic | 64 | 64 | 14 | $1,215 |
| Tecfidera Dimethyl Fumarate | 58 | 58 | Under 11 | $541K |
| Aubagio Teriflunomide | 53 | 53 | Under 11 | $494K |
| Amitriptyline Hcl Generic | 51 | 57 | 11 | $396 |
| Amantadine Amantadine Hcl | 44 | 46 | Under 11 | $1,212 |
| Primidone Generic | 44 | 46 | Under 11 | $1,022 |
Brand drugs: 820 claims; generic drugs: 1,541 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia de Jesus $20K ($20K in general payments such as food, travel and fees) from 14 companies. The largest payer was TG Therapeutics, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 11 | $17K |
| Biogen, Inc. BIIB | 28 | $778 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $355 |
| Amgen Inc. AMGN | 5 | $293 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $287 |
| EMD Serono, Inc. MRK.DE | 6 | $266 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $264 |
| Abbvie Inc. ABBV | 10 | $260 |
| Genentech, Inc. ROG.SW | 2 | $163 |
| Genentech USA, Inc. ROG.SW | 8 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.